[IKT] YoY Annual Result on 31-Dec-2021 [#FY]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
31-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#FY]
Profit Trend
YoY- -414.63%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 261 123 3,101 698 1,123 4,041 2,061 -29.12%
PBT -19,029 -18,054 -14,786 -2,848 -5,723 -2,152 -436 87.58%
Tax 0 -149 20 29 25 -161 -405 -
NP -19,029 -17,905 -14,806 -2,877 -5,748 -2,152 -436 87.58%
Tax Rate - - - - - - - -
Total Cost 19,289 18,029 17,907 3,576 6,871 6,193 2,497 40.57%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -7,304.75 -14,505.22 -477.52 -411.94 -511.95 -53.27 -21.16 164.74%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -3.57 -4.26 -4.88 -1.72 -3.34 -1.61 -0.25 55.72%
EPS Diluted -3.57 -4.26 -4.88 -1.72 -3.34 -1.61 -0.25 55.72%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.